期刊文献+

替米沙坦对糖尿病肾病大鼠肾组织Ⅰ型1,4,5-三磷酸肌醇受体表达的影响

Effect of telmisartan on expression of type Ⅰ inositol 1,4,5-trisphosphate receptor in kidney tissues of diabetic nephropathy rats
下载PDF
导出
摘要 目的:探讨替米沙坦对糖尿病肾病(DN)大鼠肾组织Ⅰ型1,4,5-三磷酸肌醇受体(IP3R)蛋白及mRNA表达的影响。方法:50只SD大鼠分为5组,即正常对照组(NC组)、DN6周组(D6组)、DN12周组(D12组)、替米沙坦治疗6周组(T6组)和替米沙坦治疗12周组(T12组),各组10只。D6、T6、D12和T12组大鼠制作DN动物模型,造模成功后T6和T12组分别给予替米沙坦治疗6和12周。采用免疫组织化学SP法检测各组大鼠肾组织Ⅰ型ⅠP3R蛋白的表达,RT-PCR测定其mRNA的表达。结果:5组大鼠肾组织Ⅰ型IP3R蛋白和mRNA表达的比较,差异有统计学意义(F=42.321和59.482,P均<0.001);T6、D6、T12和D12组较NC升高,T6组较D6组下降,T12组较D12组下降(P均<0.05)。结论:替米沙坦可能通过降低Ⅰ型IP3R的表达治疗DN。 Aim: To detect the expression of type Ⅰ inositol 1,4,5-triphosphate receptors(IP3R) protein and mRNA in kidney tissues of rats with diabetic rephropathy.Methods:A total of 50 SD rats were divided into 5 groups: normal control(NC group),DN without treatment for 6 weeks(D6 group),DN for 12 weeks(D12 group),and telmisartan treatment for 6 weeks(T6 group),and telmisartan treatment for 12 weeks(T12 group).Immunohistochemistry and reverse transcription PCR(RT-PCR) were used to detect the protein and mRNA expression of typeⅠIP3R in the kidney tissues.Results:The protein and mRNA expression of IP3R type among 5 groups had significant differences(F=42.321 and 59.482,P0.001).The expression of type ⅠIP3R were higher in groups T6,D6,T12 and D12 than that in group NC;compared with that in group D6,it decreased in group T6;comopared with that in group D12,it decreased in group T12(P0.05).Conclusion:Telmisartan could treat DN through decreasing the expression of type Ⅰ IP3R in the kidney.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2011年第3期376-378,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省卫生厅重大科技攻关基金资助项目20090107
关键词 糖尿病肾病 1 4 5-三磷酸肌醇受体 替米沙坦 大鼠 diabetic nephropathy 1 4 5-triphosphate receptor telmisartan rat
  • 相关文献

参考文献2

二级参考文献21

  • 1吕飒,宋红丽,王静艳,刘沛.急性肝坏死小鼠血脑屏障通透性的改变[J].世界华人消化杂志,2004,12(6):1346-1348. 被引量:10
  • 2姚宇玫,胡申江,黄元伟,杨春虎,孙坚,朱朝晖,吴涛.肿瘤坏死因子α对心肌细胞内受磷蛋白表达和细胞内钙的调节作用[J].中国医学科学院学报,2005,27(6):767-771. 被引量:4
  • 3Feuvray D. Diabetic cardiomyopathy. Arch Mal Coeur Vaiss,2004,97 ( 3 ) : 261.
  • 4Tarantini L, Di Lenarda A, Velussi M, et al. Diabetes mellitus, left ventricular dysfunction and congestive heart failure.ltal Heart J Suppl, 2004,5(8) :605.
  • 5Bonnefont-Rousselot D. The role of antioxidant micronutrients in the prevention of diabetic complications. Treat End0crinol,2004,3(1) :41.
  • 6Candido R, Forbes JM, Thomas MC,et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res,2003,92(7) : 785.
  • 7Laakso M. Hyperglycaemia and cardiovascular disease in type 2 diabetes. Diabetes,1999,48(5 ) :937.
  • 8Montilla PL, Vargas JF, Tunez IF, et al. Oxidative stress in diabetic rats induced by streptozotoxin: protective effects of melatonin. J Pineal Res, 1998, 25(2) : 94.
  • 9Dellis O, Dedos SG, Tovey SC, et al. Ca^2+ entry through plasma membrane IP3 receptors. Science, 2006, 313: 229-233.
  • 10McGowan TA, Sharma K. Regulation of inositol 1,4,5-trisphosphate receptors by transforming growth factor-beta: implications for vascular dysfunction in diabetes. Kidney Int Suppl, 2000, 77: 99-103.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部